4 ms·
I, probably with many others, didn't realize this could be the consequence of an EUA until you mentioned it here. Thank you.
by pieter_mj 4y ago
I, probably with many others, didn't realize this could be the consequence of an EUA until you mentioned it here. Thank you.
- snowwrestler 4y agoIt's not specific to EUA, this is commonly done when a Phase 3 trial shows a clear benefit. Essentially, once you're sure a medicine confers a real benefit, it becomes unethical to deny it to the control branch any longer.